These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 14759316)

  • 41. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
    Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
    Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral zinc therapy for Wilson's disease.
    Brewer GJ; Hill GM; Prasad AS; Cossack ZT; Rabbani P
    Ann Intern Med; 1983 Sep; 99(3):314-9. PubMed ID: 6614680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Penicillamine hepatotoxicity in the treatment of Wilson's disease.
    Menara M; Zancan L; Sturniolo GC
    J Pediatr Gastroenterol Nutr; 1992 Apr; 14(3):353-4. PubMed ID: 1619543
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 50. Wilson's Disease: A Review for the General Pediatrician.
    Capone K; Azzam RK
    Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
    Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
    Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
    Hoogenraad TU; Van Hattum J; Van den Hamer CJ
    J Neurol Sci; 1987 Feb; 77(2-3):137-46. PubMed ID: 3819764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
    Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
    J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease.
    Sakaida I; Kawaguchi K; Kimura T; Tamura F; Okita K
    J Gastroenterol; 2005 Jun; 40(6):646-51. PubMed ID: 16007400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc?
    Lipsky MA; Gollan JL
    Hepatology; 1987; 7(3):593-5. PubMed ID: 3570170
    [No Abstract]   [Full Text] [Related]  

  • 58. Wilson's disease.
    Pfeiffer CC; Camo B
    Arch Neurol; 1988 Mar; 45(3):247. PubMed ID: 3341945
    [No Abstract]   [Full Text] [Related]  

  • 59. The treatment of Wilson's disease in paediatrics: oral zinc therapy versus penicillamine.
    Cossack ZT; Bouquet J
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():514-7. PubMed ID: 3776618
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical presentation and treatment of Wilson's disease: a single-centre experience.
    Pellecchia MT; Criscuolo C; Longo K; Campanella G; Filla A; Barone P
    Eur Neurol; 2003; 50(1):48-52. PubMed ID: 12824712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.